AVEO Pharmaceuticals Inc

0.00 (-0.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)518.86M
Current PEN/A
Forward PE N/A
2yr Forward PE 34.7
See more stats
Estimates Current Quarter
Revenue$34.78 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$14.88
50-Day MA$12.74
200-Day MA$7.57
See more pivots

AVEO Pharmaceuticals Inc Stock, NASDAQ:AVEO

30 Winter Street, 14th floor, Boston, Massachusetts 02108
United States of America
Phone: +1.617.400.0101
Number of Employees: 115


AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.